TLR5 and neoplasm: While it has been shown that mice bearing tumor cells lacking TLR5 fail to respond to treatment with flagellin26, it remains to be studied whether flagella and CBLB502 can also act on the tumor cells to elicit a curative immune response in the context of combination treatment with ICT.